Literature DB >> 6203205

Biochemical markers in prostatic cancer.

M J Schacht, J E Garnett, J T Grayhack.   

Abstract

The status of the biochemical markers explored for use in patients with carcinoma of the prostate is reviewed. No unique marker has been identified. However, a variety of substances, primarily enzymes and specific proteins, found in the serum, urine, and prostatic fluid, have been evaluated. Their main value remains in the staging of disease and the monitoring of response to therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203205

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  4 in total

1.  Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.

Authors:  Michael L Eisenberg; Benjamin J Davies; Matthew R Cooperberg; Janet E Cowan; Peter R Carroll
Journal:  Eur Urol       Date:  2009-04-03       Impact factor: 20.096

2.  Plasma osteocalcin values and related hormonal parameters in patients subjected to a variety of prostate anticancer agents.

Authors:  M Tarle
Journal:  Urol Res       Date:  1991

3.  Platinum-based chemotherapy for variant castrate-resistant prostate cancer.

Authors:  Ana M Aparicio; Andrea L Harzstark; Paul G Corn; Sijin Wen; John C Araujo; Shi-Ming Tu; Lance C Pagliaro; Jeri Kim; Randall E Millikan; Charles Ryan; Nizar M Tannir; Amado J Zurita; Paul Mathew; Wadih Arap; Patricia Troncoso; Peter F Thall; Christopher J Logothetis
Journal:  Clin Cancer Res       Date:  2013-05-06       Impact factor: 12.531

Review 4.  Diagnosis of prostate cancer via nanotechnological approach.

Authors:  Benedict J Kang; Minhong Jeun; Gun Hyuk Jang; Sang Hoon Song; In Gab Jeong; Choung-Soo Kim; Peter C Searson; Kwan Hyi Lee
Journal:  Int J Nanomedicine       Date:  2015-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.